Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think this is needing a stronger Pl to help in the move up. need to attract investors and perhaps buyers of the company??
Strong close, This company is going to have strong growth from here on out as adoption grows. IMHO.
Next ISRG in the making. As they have more adoption, sales of cassettes with sore. I predict profitable by 4th quarter. Possibly 3rd. Go cvrs. IMHO
* * $CVRS Video Chart 05-08-2019 * *
Link to Video - click here to watch the technical chart video
Video about Verizon 5g Network with Corindus Robotics.
Skip to 1:25.
https://dms.licdn.com/playback/C4E05AQEWRdglAbUeag/e56200188f7443669bedc365a5b4c2aa/feedshare-mp4_3300-captions-thumbnails/1507940147251-drlcss?e=1556852400&v=beta&t=_xBnWltSrIi4lykhwdITyEBElX1pNcvOp_YRVZ5OTsw
Integrated Core Strategies (us) Llc has filed a new 13G, reporting 5.1% ownership in CVRS
https://fintel.io/so/us/cvrs
* * $CVRS Video Chart 04-29-2019 * *
Link to Video - click here to watch the technical chart video
News: $CVRS Corindus to Report First Quarter 2019 Financial Results on May 7, 2019
Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release first quarter 2019 financial and business results on Tuesday, May 7, 2019 after the close of the U.S. financial markets. Mark Toland, President...
In case you are interested https://marketwirenews.com/news-releases/corindus-to-report-first-quarter-2019-financial-results-on-may-7-2019-8077864.html
MAYBE A PLACE FOR THIS PLAY TO GET SOLD???
Both directors just bought more shares April 5
http://www.conferencecalltranscripts.org/4/summary/?id=6035590
The ‘next big thing’ in tech is hiding among the small caps!!! $$$$
https://www.marketwatch.com/story/the-next-big-thing-in-tech-is-hiding-among-the-small-caps-2019-03-29?siteid=yhoof2&yptr=yahoo
Daily & Weekly technicals Very Explosive!!! Fun Begins above 2.55 $$$ CEO is Holding almost 9 million shares and She will lead it to the promise land BOOM!!! $$$
CEO Loaded 573,000 Shares @ 1.80 Then A direct Investor Investing $25 Million BOOM!!! $$$$$
Accumulated 61,000 Shares Under 2.20 Today, BOOM $$$$ See ya'll @ $10.00 Promise!!! $$$$
This is way undervalued and finally people are starting to figure that out. Just the beginning. This technology is a game changer.
Small news article from The Virginian Pilot
https://pilotonline.com/news/local/health/article_1b8547e4-4b66-11e9-953e-3352224fa0a2.html
Director Louis A. Cannon just picked up another 10,000 shares.
http://www.conferencecalltranscripts.org/4/summary/?id=5969762
The momentum traders and shorts with a few stop loss sells is all it was. I believe we will settle between 1.50 and 2. Waiting on the next big news. IMHO
It did go up over 100 percent in a few days I mean I don't blame them for bringing it back down. This company is growing fast News is coming. JAPAN. Possible partner , etc. I still think we will see 3-5 if not more. Very soon. Robotic surgery is becoming standard of care. Cvrs is the only one doing vascular robotic intervention. GO BABY GO
Are we just seeing volitility or are we seeing a return to ~$1.0? Long term hold?
From the 10K
"In June 2018, we secured Pharmaceutical and Medical Device Agency (“PMDA”) approval to market the CorPath GRX System in Japan. We are working with our distributor towards reimbursement for robotic-assisted PCI as the final step in preparing for the commercial launch of CorPath GRX in Japan, which we expect to occur in the first half of 2019."
MIGHT SEE NEW 52 WEEK HIGH TODAY. THE BABY HAS LEGS
STORY on channel 23 News last night think it was posted on TWITTER
GO BABY GO
Took profits today
Held from .90.
Just a feeling right or wrong. But it’s green
take a look at the early days of ISRG the upside is huge, if they can show that the doctors will adopt the tech. we will see that by an increase in cassette sales. more cassettes sold the more operations are being done. Partnership or buyout coming soon IMHO
New to this board and just took a position in low 2’s. Fascinated by this technology but have know idea what the upside is here on just thie current status ( mainly market cap ). Any thoughts? Thanks !
Kickin' serious bootay...lots to like here
Yep, said that a year ago and it even looks better today
This company is also a perfect candidate for a buyout. Especially at this price. Way undervalued even at 2.25. IMHO
I think once the insiders are all done buying we will get some big news . Hopefully about a partner . Then we fly to 4-5 IMHO.
CVRS here we go...monster in da making!! its about time this great little company had its day!!
Followers
|
21
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
431
|
Created
|
06/06/12
|
Type
|
Free
|
Moderators |
Corindus Vascular Robotics, Inc.(CVRS) is a global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The Company?s FDA-cleared CorPath System is the first medical device that offers interventional cardiologists PCI procedure control from a radiation protective interventional cockpit. With the CorPath System, Corindus Vascular Robotics brings robotic precision to PCI procedures to help optimize clinical outcomes and minimize the costs associated with complications through of improper stent placement with manual PCI procedures.
Dr. Vijay Lyer's Story
Interventional cardiologist, Dr. Vijay Iyer, has spent his career providing lifesaving care to his patients, all while wearing heavy lead apparel to protect himself from the harmful effects of radiation exposure required for his procedures. Unfortunately, the lead apparel required during percutaneous coronary interventions, or PCI, and other procedures in the cath lab has led to serious spinal injuries for Dr. Iyer. After four back surgeries, Dr. Iyer was faced with the grim reality that one more surgery may end his career in the cath lab. The orthopedic injuries he faced are unfortunately very common among interventional cardiologists and other cath lab personnel with 60% of interventionalists with more than 20 years in the lab experiencing spinal issues.
Dr. Iyer was committed to finding a solution that would allow him to continue in interventional cardiology without the need for heavy lead apparel. This video highlights how Dr. Iyer is avoiding further injury by routinely utilizing CorPath, the first robotic system cleared for PCI, which enables him to provide a high level of care for his patients from the safety of a radiation-protected interventional cockpit.
http://www.corindus.com/news-events/press-releases/september-16-2015
How it works
http://www.corindus.com/corpath-grx/how-it-works
Market Value1 | $286,233,809 | a/o Jun 13, 2017 | |
Authorized Shares | 250,000,000 | a/o Dec 31, 2014 | |
Outstanding Shares | 187,080,921 | a/o May 08, 2017 |
Common Stock, $0.0001 Par Value | Additional Paid-in | Accumulated | ||||||||||||||||||
Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
Balance at December 31, 2016 | 119,025,221 | $ | 12 | $ | 150,776 | $ | (146,718 | ) | $ | 4,070 | ||||||||||
Stock-based compensation expense | — | — | 792 | — | 792 | |||||||||||||||
Issuance of common stock in connection with private placement of common stock, net of issuance costs of $415 | 68,055,700 | 7 | 44,604 | — | 44,611 | |||||||||||||||
Net loss | — | — | — | (9,885 | ) | (9,885 | ) | |||||||||||||
Balance at March 31, 2017 | 187,080,921 | $ | 19 | $ | 196,172 | $ | (156,603 | ) | $ | 39,588 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |